A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector

Molecular Therapy

Volumn 3, Issue 4, 2001, Pages 613-622

  Zhou, Heshan ^a,b   Zhao, Tiejun ^a,b   Pastore, Lucio ^b   Nageh, Maged ^b   Zheng, Wendy ^a,b   Rao, X Mei ^a   Beaudet, Arthur L ^b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CONTAMINATION; CONTROLLED STUDY; DNA PACKAGING; GENE DELETION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC CODE; GENETIC STABILITY; GENETIC TRANSDUCTION; HELPER VIRUS; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; MAMMAL CELL; PATHOGENICITY; PROTEIN SYNTHESIS; SAFETY; TRANSGENE; VIRUS GENOME;

ADENOVIRIDAE; MAMMALIA;

EID: 0034984662     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0288     Document Type: Article

References (59)

1. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector
2. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo
3. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver
4. Adenovirus as an expression vector in muscle cells in vivo
5. Human adenovirus vectors for gene transfer into mammalian cells
6. Is gene therapy in cystic fibrosis a realistic expectation?
7. Gene therapy death prompts review of adenovirus vector
8. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses
9. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene
10. Adenoviridae: The viruses and their replication
11. Dissection of overlapping functions within the adenovirus type 5 E1A gene
12. Genetic analysis of adenoviruses
13. Common control of the heat shock gene and early adenovirus genes: Evidence for a cellular E1A-like activity
14. Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation
15. Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy
16. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA
17. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes
18. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
19. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line
20. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (DE1 + DE3) during multiple passages in 293 cells
21. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence
22. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector
23. Functional analysis of the nucleotide sequence surrounding the cap site for adenovirus type 5 region E1A messenger RNAs
24. Adenovirus E1A under the control of heterologous promoters: Wide variation in E1A expression levels has little effect on virus replication
25. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins
26. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted
27. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy
28. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted
29. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted
30. A new vector system with inducible cell line E2T for production of safer and higher titer adenoviral vectors
31. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro
32. Lack of persistence of E1 - Recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs
33. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: Comparison of E2a wild type and E2a deleted vectors
34. Next-generation adenoviral vectors: New and improved
35. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector
36. Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre
37. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
38. High doses of a helper-dependent adenovirus vector yield supraphysiological levels of a1-antitrypsin with negligible toxicity
39. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
40. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
41. Helper-dependent adenoviral vector-mediated gene transfer in aged rat brain
42. Persistence in muscle of an adenoviral vector that lacks all viral gene
43. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells
44. Adenovirus-mediated regulable target gene expression in vivo
45. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system
46. Gene therapy: The need for basic science
47. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
48. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
49. Optimization of the helper-dependent adenovirus system for production and potency in vivo
50. Chromosome engineering in mice
51. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
52. A regulatory system for use in gene transfer
53. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 α
54. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
55. Manipulation of adenovirus vectors
56. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
57. Detection of specific sequences among DNA fragments separated by gel electrophoresis
58. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
59. Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response